Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)

NCT: NCT04470934 · ACTIVE_NOT_RECRUITING

NCT IDNCT04470934
StatusACTIVE_NOT_RECRUITING
Start Date2021-04-30
Completion2027-03-31
SponsorB. Braun Melsungen AG (INDUSTRY)
First posted
Last updated

Brief Summary

The aim of the study is to assess continued safety and efficacy of the SeQuent® SCB. The product under investigation will be used in routine clinical practice according to the latest European Society of Cardiology (ESC) guidelines and according to the Instructions for Use (IFU). Those data that are obtained in routine clinical use will be documented in the Case Report Form (CRF).

Frequently Asked Questions

What is SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)?

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) is a clinical trial registered under NCT04470934. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04470934?

The current status of NCT04470934 (SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)) is: ACTIVE_NOT_RECRUITING.

When did SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) start?

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) started on 2021-04-30.

Related Devices

K152050PencylcapB.Braun Melsungen AG K163358Introcan Safety 3 Closed IV CatheterB.Braun Melsungen AG

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑